Search alternatives:
trials » trial (Expand Search)
Showing 61 - 80 results of 129 for search 'trials published', query time: 0.09s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64
  5. 65
  6. 66
  7. 67

    The impact of psoriatic arthritis on quality of life: a systematic review by James, L, Hailey, L, Suribhatia, R, McGagh, D, Amarnani, R, Bundy, C, Kirtley, S, O'Sullivan, D, Steinkoenig, I, White, J, Vivekanantham, A, Coates, LC

    Published 2024
    “…The inclusion criteria were studies published between 2010 and 2021 that used outcomes validated in patients with PsA. …”
    Journal article
  8. 68

    A service evaluation of the implementation of a novel digital intervention for hypertension self-monitoring and management system in primary care (SHIP): protocol for a mixed metho... by Smith, A, Tucker, KL, Barnes, RK, Drakesmith, CW, Agwunobi, A, Bateman, PA, Forbes, A, de Lusignan, S, Ford, GA, Fujiwara, T, Hobbs, FR, Koshiaris, C, Mant, J, McKinstry, B, Pollock, S, Rice, C, Yang, Y, McManus, RJ

    Published 2024
    “…Background: Hypertension is a key risk factor for death and disability, and blood pressure reduction is associated with significant reductions in cardiovascular risk. Large trials have shown that interventions including self-monitoring of blood pressure can reduce blood pressure but real-world data from wider implementation are lacking. …”
    Journal article
  9. 69
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74

    Enhancement of lentiviral vector production through alteration of virus-cell interactions by Gelinas, J

    Published 2016
    “…They have been successfully used in <em>ex vivo</em> clinical trials for several haematopoietic stem cell disorders. …”
    Thesis
  15. 75
  16. 76
  17. 77
  18. 78
  19. 79

    Expediting treatments in the 21st century: orphan drugs and accelerated approvals by Domike, Reuben, Raju, G. K., Sullivan, Jamie, Kennedy, Annie

    Published 2024
    “…Methods The following U.S. FDA CDER published lists were used in this analysis: 1. all orphan designations and approvals; 2. all AA and their details updated through December 31, 2022; new molecular entities (NMEs). …”
    Get full text
    Article
  20. 80